118 related articles for article (PubMed ID: 32688340)
1. Genotype-phenotype associations in PPGLs in 59 patients with variants in SDHX genes.
Main AM; Rossing M; Borgwardt L; Grønkær Toft B; Rasmussen ÅK; Feldt-Rasmussen U
Endocr Connect; 2020 Aug; 9(8):793-803. PubMed ID: 32688340
[TBL] [Abstract][Full Text] [Related]
2. Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers.
White G; Velusamy A; Anandappa S; Masucci M; Breen LA; Joshi M; McGowan B; Hubbard JGH; Obholzer R; Christodoulou D; Jacques A; Touska P; Hassan FU; Izatt L; Carroll PV
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35060925
[TBL] [Abstract][Full Text] [Related]
3. First-positive surveillance screening in an asymptomatic SDHA germline mutation carrier.
White G; Tufton N; Akker SA
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019(1):. PubMed ID: 31368675
[TBL] [Abstract][Full Text] [Related]
4. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
5. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
6. Molecular Alterations in Dog Pheochromocytomas and Paragangliomas.
Korpershoek E; Dieduksman DAER; Grinwis GCM; Day MJ; Reusch CE; Hilbe M; Fracassi F; Krol NMG; Uitterlinden AG; de Klein A; Eussen B; Stoop H; de Krijger RR; Galac S; Dinjens WNM
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31052272
[TBL] [Abstract][Full Text] [Related]
7. Risk Stratification on Pheochromocytoma and Paraganglioma from Laboratory and Clinical Medicine.
Kimura N; Takekoshi K; Naruse M
J Clin Med; 2018 Aug; 7(9):. PubMed ID: 30150569
[TBL] [Abstract][Full Text] [Related]
8. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments.
Papathomas TG; de Krijger RR; Tischler AS
Semin Diagn Pathol; 2013 Aug; 30(3):207-23. PubMed ID: 24144290
[TBL] [Abstract][Full Text] [Related]
9. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
10. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma.
Muth A; Crona J; Gimm O; Elmgren A; Filipsson K; Stenmark Askmalm M; Sandstedt J; Tengvar M; Tham E
J Intern Med; 2019 Feb; 285(2):187-204. PubMed ID: 30536464
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
13. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
[TBL] [Abstract][Full Text] [Related]
14. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
15. Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.
Bennedbæk M; Rossing M; Rasmussen ÅK; Gerdes AM; Skytte AB; Jensen UB; Nielsen FC; Hansen TVO
Hered Cancer Clin Pract; 2016; 14():13. PubMed ID: 27279923
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
17. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes.
Michałowska I; Lewczuk A; Ćwikła J; Prejbisz A; Swoboda-Rydz U; Furmanek MI; Szperl M; Januszewicz A; Pęczkowska M
Pol J Radiol; 2016; 81():510-518. PubMed ID: 27867439
[TBL] [Abstract][Full Text] [Related]
19. SDHC Promoter Methylation, a Novel Pathogenic Mechanism in Parasympathetic Paragangliomas.
Bernardo-Castiñeira C; Valdés N; Sierra MI; Sáenz-de-Santa-María I; Bayón GF; Perez RF; Fernández AF; Fraga MF; Astudillo A; Menéndez R; Fernández B; Del Olmo M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2018 Jan; 103(1):295-305. PubMed ID: 29126304
[TBL] [Abstract][Full Text] [Related]
20. Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.
van Berkel A; Rao JU; Kusters B; Demir T; Visser E; Mensenkamp AR; van der Laak JA; Oosterwijk E; Lenders JW; Sweep FC; Wevers RA; Hermus AR; Langenhuijsen JF; Kunst DP; Pacak K; Gotthardt M; Timmers HJ
J Nucl Med; 2014 Aug; 55(8):1253-9. PubMed ID: 24925884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
